ZyVersa Therapeutics (ZVSA) Revenue & Revenue Breakdown
ZyVersa Therapeutics Revenue Highlights
00
ZyVersa Therapeutics Revenue by Period
ZyVersa Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
ZyVersa Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ZyVersa Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $26.08K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $15.60K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | - |
ZyVersa Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
ZyVersa Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CDT | CDT Equity | $2.46B | $698.22M |
| WORX | SCWorx | $2.99M | $682.63K |
| ONCO | Onconetix | $58.47K | $106.49K |
| ZVSA | ZyVersa Therapeutics | - | - |
| XAGE | Longevity Health | - | $20.52K |
| INDP | Indaptus Therapeutics | - | - |
| ENVB | Enveric Biosciences | - | - |
| NIVF | NewGenIvf Group | - | - |
| JSPR | Jasper Therapeutics | - | - |
| SLXN | Silexion Therapeutics | - | - |